Claims for Patent: 4,278,593

Summary for Patent: 4,278,593

Title:	Glucocorticoid sparing factor and process for the production of the same
Abstract:	A glucocorticoid sparing factor (GSF) which amplifies liver enzyme induction which is caused in glucocorticoid and a process for the production of GSF are disclosed. GSF can be isolated from the culture broth of a microorganism of the Family Enterobacteriaceae.
Inventor(s):	Katsunuma; Nobuhiko (Shomachi, Tokushima-shi, Tokushima-ken, JP)
Assignee:
Application Number:	06/109,095
Patent Claims:	1. A glucocerticoid sparing factor characterized in that: it is a colorless and acidic substance produced in a culture broth of a microorganism of the Family Enterobacteriaceae; it has a molecular weight between about 400 and about 1,000; it is a uridine derivative having uracil, pentose, hexose and phosphate radical which can be easily hydrolyzed by the action of acids; it amplifies the liver enzyme induction, with said amplifying action being deactivated by the action of .alpha.-glucosidase and phosphodiesterase II, but not being affected by the action of .alpha.-amylase, neuraminidase, hyaluronidase, lysozyme, chymotripsin, trypsin, pepsin, proteinase, papain, collagenase, aminopeptidase M, carboxypeptidases A and B, leucine-aminopeptidase, deoxyribonuclease 1, ribonuclease T.sub.1 +A, acid phosphatase or alkali phosphatase; it is stable for more than 6 months at -20.degree. C.; it is stable for minimum of 48 hours in a buffer solution having a pH of 4.2-9 at 37.degree. C.; it is deactivated to form reducing sugar when heated at 105.degree. C. for 12 hours in 6 N hydrochloric acid; it has a peak at 260 nm in the ultraviolet absorption spectrum; and it has an Rf of about 0.51 as measured by ascending method using filter paper and isopropanol-aqueous ammonia-water (7:1:2 v/v) as a developing agent. 2. A process for the production of the glucocorticoid sparing factor according to claim 1 which comprises cultivating a microorganism of the Family Enterobacteriaceae and isolating said factor from the bacterial cells. 3. A process for the production of the glucocorticoid sparing factor according to claim 1 which comprises cultivating a microorganism of the Family Enterobacteriaceae, extracting the bacterial substance from the propagated cells by destructing said cells, deproteinizing the extract, causing the extract to be adsorbed on activated charcoal, eluting the adsorbate with an organic solvent-containing solution, and purifying the eluate with gel filtration, column chromatography on ion exchange resin or paper chromatography. 4. A process in accordance with claim 3 wherein said organic solvent-containing solution is selected from the group consisting of 0.2 N aqueous potassium hydroxide-acetone (3:7, v/v) and 10-30% aqueous ethanol. 5. A process in accordance with claim 3 wherein said gel filtration is effected with the use of a filter medium selected from the group consisting of those under the trade names of Sephadex G, Sephadex LH-20 and Polystyrene gel G 3000S. 6. A process in accordance with claim 3 wherein said ion exchange resin for the column chromatography is selected from the group consisting of DEAE cellulose and those under the trade name of Dowex. 7. A process in accordance with claim 3 wherein said microorganism of the Family Enterobacteriaceae is selected from the group consisting of those belonging to the general Escherichia, Aerobacter, Klebsiella, Paracolobactrum, Alginobactor, Erwinia, Serratia, Salmonella, Proteus and Shigella. 8. A process in accordance with claim 3 wherein said microorganism of the Family Enterobacteriaceae is selected from the group consisting of Escherichia coli, Erwinia aroideae, Erwinia carotovora, Serratia marcesens, Proteus mirabilis, Proteus vulgaris, Proteus morganii and Aerobactor aerogenes.

Details for Patent 4,278,593

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	05/05/2004		1999-01-11
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	12/02/2004		1999-01-11
Amphastar Pharmaceuticals, Inc.	AMPHADASE	hyaluronidase	Injection	021665	10/26/2004		1999-01-11
Akorn, Inc.	HYDASE	hyaluronidase	Injection	021716	10/25/2005		1999-01-11
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		1999-01-11